stocktools
Offerings // Can-Fite BioPharma Ltd.

CANF offering history

Every offering-related filing in Can-Fite BioPharma Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 858 filings back to Dec 1, 2011.

Last executed offering
Jul 29, 2025
424B4 — priced deal (shares or notes)
Last registration (announced)
Aug 28, 2026
F-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Sep 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 28, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Apr 3, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 3, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 31, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Mar 31, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 31, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 5, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 21, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 11, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 11, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 29, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 28, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 25, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jul 23, 2025F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
May 9, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 17, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 15, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 6, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 6, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 30, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 30, 2024F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jun 28, 2024424B7 →UPDATEResale prospectus — existing holders registering to sell
Apr 9, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 28, 2023F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Dec 12, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 22, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 12, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 8, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 1, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Apr 24, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 10, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Feb 10, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 10, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 31, 2023F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jan 13, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 13, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
CANF offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CANF workspace →
CANF offering FAQ

When did CANF last execute an offering?

Per SEC filings, Can-Fite BioPharma Ltd.'s most recent priced offering document is a 424B4 filed 2025-07-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CANF last announce or register an offering?

The most recent registration is a F-3 filed 2026-08-28. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.